rs76297160

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001378609.3(OTOGL):​c.1126A>G​(p.Ile376Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00198 in 1,588,680 control chromosomes in the GnomAD database, including 62 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 30 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 32 hom. )

Consequence

OTOGL
NM_001378609.3 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 3.49

Publications

2 publications found
Variant links:
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
OTOGL Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 84B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004940301).
BP6
Variant 12-80251766-A-G is Benign according to our data. Variant chr12-80251766-A-G is described in ClinVar as Benign. ClinVar VariationId is 226926.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0104 (1589/152230) while in subpopulation AFR AF = 0.036 (1496/41528). AF 95% confidence interval is 0.0345. There are 30 homozygotes in GnomAd4. There are 748 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 30 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGLNM_001378609.3 linkc.1126A>G p.Ile376Val missense_variant Exon 12 of 59 ENST00000547103.7 NP_001365538.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGLENST00000547103.7 linkc.1126A>G p.Ile376Val missense_variant Exon 12 of 59 5 NM_001378609.3 ENSP00000447211.2 Q3ZCN5
OTOGLENST00000646859.1 linkc.1126A>G p.Ile376Val missense_variant Exon 17 of 63 ENSP00000496036.1 A0A2R8YF04
OTOGLENST00000643417.1 linkn.1786A>G non_coding_transcript_exon_variant Exon 15 of 23

Frequencies

GnomAD3 genomes
AF:
0.0104
AC:
1584
AN:
152112
Hom.:
29
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0360
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00471
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00272
AC:
562
AN:
206564
AF XY:
0.00218
show subpopulations
Gnomad AFR exome
AF:
0.0389
Gnomad AMR exome
AF:
0.00159
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000792
Gnomad OTH exome
AF:
0.00133
GnomAD4 exome
AF:
0.00109
AC:
1562
AN:
1436450
Hom.:
32
Cov.:
30
AF XY:
0.000974
AC XY:
693
AN XY:
711600
show subpopulations
African (AFR)
AF:
0.0393
AC:
1302
AN:
33134
American (AMR)
AF:
0.00199
AC:
82
AN:
41118
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25580
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39024
South Asian (SAS)
AF:
0.0000366
AC:
3
AN:
81994
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51998
Middle Eastern (MID)
AF:
0.00122
AC:
7
AN:
5720
European-Non Finnish (NFE)
AF:
0.0000300
AC:
33
AN:
1098398
Other (OTH)
AF:
0.00227
AC:
135
AN:
59484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
64
129
193
258
322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0104
AC:
1589
AN:
152230
Hom.:
30
Cov.:
32
AF XY:
0.0100
AC XY:
748
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0360
AC:
1496
AN:
41528
American (AMR)
AF:
0.00471
AC:
72
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68008
Other (OTH)
AF:
0.00710
AC:
15
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
83
166
248
331
414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00381
Hom.:
15
Bravo
AF:
0.0119
ESP6500AA
AF:
0.0356
AC:
135
ESP6500EA
AF:
0.000121
AC:
1
ExAC
AF:
0.00283
AC:
341
Asia WGS
AF:
0.00346
AC:
12
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ile367Val in exon 11 of OTOGL: This variant is not expected to have clinical sig nificance because it has been identified in 3.6% (135/3794) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs76297160). -

Feb 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
16
DANN
Benign
0.95
Eigen
Benign
-0.018
Eigen_PC
Benign
0.13
FATHMM_MKL
Benign
0.74
D
LIST_S2
Benign
0.75
T;.;T
MetaRNN
Benign
0.0049
T;T;T
MetaSVM
Benign
-0.95
T
PhyloP100
3.5
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.58
.;.;N
REVEL
Benign
0.17
Sift
Benign
0.58
.;.;T
Sift4G
Benign
0.88
.;.;T
Vest4
0.15
MVP
0.34
MPC
0.021
ClinPred
0.013
T
GERP RS
4.3
gMVP
0.25
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76297160; hg19: chr12-80645546; API